Insilico Medicine Joins HKEX Tech 100 Index

Sep 3, 2026
Insilico Medicine will join the HKEX Tech 100 Index on September 14 after changes to the index methodology.
Insilico Medicine Joins HKEX Tech 100 Index

Insilico Medicine will join the HKEX Tech 100 Index on September 14, 2026, the company announced in a press release. The change will be implemented after the market closes on September 11.

The index tracks 100 large Hong Kong listed companies with substantial exposure to technology themes and eligibility for Southbound Stock Connect. Its sectors include artificial intelligence, biotechnology and pharmaceuticals, electric vehicles, information technology, internet services, and robotics.

Insilico Medicine reported about $106 million in revenue for the first half of 2026, up 287% from the same period a year earlier. Its adjusted net profit exceeded $51 million, marking its first profitable half since listing in Hong Kong in December 2025.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

AI Funding Brief

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.